Choroidal neovascularization (CNV) is a major cause of vision loss in chronic central serous chorioretinopathy (CSCR). Detecting CNV using fluorescein angiography (FA) may be challenging owing to the coexistence of features related to the primary ...

2019年1月1日 · Choroidal neovascularization (CNV) associated with chronic central serous chorioretinopathy (CSCR) has been considered for a long time a rare and sight-threatening disease, with a poor visual prognosis. The most frequent type of CNV is located under the retinal pigment epithelium and classified as type 1 CNV.

Central serous chorioretinopathy (CSCR) is the fourth most common retinopathy after age-related macular degeneration, diabetic retinopathy, and branch retinal vein occlusion. CSCR typically occurs in men in their 20s to 50s who exhibit acute or subacute central vision loss or distortion.

2020年2月7日 · Purpose: To identify the clinical characteristics and risk factors for secondary choroidal neovascularization (CNV) in central serous chorioretinopathy (CSC). Methods: In this retrospective study, we included a total of 108 eyes in 106 CSC patients. Group A was defined as patients initially diagnosed with CSC who developed secondary CNV, and ...

2019年3月8日 · Choroidal neovascularization (CNV) is an important complication of chronic central serous chorioretinopathy (CSC). Development of CNV is one of the major causes of reduced...

2023年3月6日 · This study evaluated predictors for choroidal neovascularization (CNV) associated with central serous chorioretinopathy (CSCR) based on multimodal imaging. A retrospective multicenter chart review was conducted on 134 eyes of …

2020年2月7日 · To identify the clinical characteristics and risk factors for secondary choroidal neovascularization (CNV) in central serous chorioretinopathy (CSC). Methods . In this retrospective study, we included a total of 108 eyes in 106 CSC patients.

2019年1月1日 · Choroidal neovascularization (CNV) associated with chronic central serous chorioretinopathy (CSCR) has been considered for a long time a rare and sight-threatening disease, with a poor visual prognosis. The most frequent type of CNV is located under the retinal pigment epithelium and classified as type 1 CNV.

Intravitreal injections of bevacizumab, a humanized anti-VEGF antibody which inhibits VEGF-A protein has been reported to produce favorable results in CNV from various etiologies. Our patient had active CSCR along with classic subfoveal CNV. The role of VEGF and anti-VEGF agents in CSCR has not been studied widely.

To analyse the longitudinal changes in visual acuity and risk factors for recurrence or development of choroidal neovascularisation (CNV) in eyes with acute or chronic central serous chorioretinopathy (CSCR). This was a retrospective, multicentric, ...